Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
NA
266 participants
INTERVENTIONAL
2018-07-16
2026-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Test Arm 1
Single vision, impact-resistant spectacle lenses
Novel spectacle lens design
Use of lenses may reduce the rate of progression of juvenile myopia
Test Arm 2
Single vision, impact-resistant spectacle lenses
Novel spectacle lens design
Use of lenses may reduce the rate of progression of juvenile myopia
Test Arm 3
Single vision, impact-resistant spectacle lenses
Spectacle lenses
Use of lenses may reduce the rate of progression of juvenile myopia
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Novel spectacle lens design
Use of lenses may reduce the rate of progression of juvenile myopia
Spectacle lenses
Use of lenses may reduce the rate of progression of juvenile myopia
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* SER error between -0.75 and -4.50 D
* SER power between the two eyes must be less than or equal to 1.50 D
* Willingness to participate in the trial for 3 years without content lens wear
Exclusion Criteria
* Previous or current use of bifocals, progressive addition spectacles lenses
* Previous or current use of myopia control treatment
* Astigmatism worse then -1.25 DC in either eye
6 Years
10 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
SightGlass Vision, Inc.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Joseph Rappon, OD, MS, FAAO
Role: STUDY_CHAIR
SightGlass Vision, Inc.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Golden Optometric Group
Whittier, California, United States
Sabal Eye Care
Longwood, Florida, United States
Visual Performance Center
Pensacola, Florida, United States
Kannarr Eye Care
Pittsburg, Kansas, United States
Eye Associates of Northeast Louisiana (DBA Haik Humble Eye Center) Research Dept
West Monroe, Louisiana, United States
Advanced Eyecare, PC
Raytown, Missouri, United States
SUNY School of Optometry
New York, New York, United States
Sacco Eye Group
Vestal, New York, United States
Dept of Clinical Research, South Shore Eye Care, LLP
Wantagh, New York, United States
Dunes Eye Consultants
Dakota Dunes, South Dakota, United States
Total Eye Care
Memphis, Tennessee, United States
University of Houston College of Optometry
Houston, Texas, United States
William J Bogus, OD, FAAO
Salt Lake City, Utah, United States
Center for Ocular Research & Education, School of Optometry, University of Waterloo School of Optometry & Vision Science
Waterloo, Ontario, Canada
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Rappon J, Chung C, Young G, Hunt C, Neitz J, Neitz M, Chalberg T. Control of myopia using diffusion optics spectacle lenses: 12-month results of a randomised controlled, efficacy and safety study (CYPRESS). Br J Ophthalmol. 2023 Nov;107(11):1709-1715. doi: 10.1136/bjo-2021-321005. Epub 2022 Sep 1.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CPRO-1802-001
Identifier Type: -
Identifier Source: org_study_id